AcelRx Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. AcelRx Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 63% to $651,000. The net income dropped to -$10,287,000 and profit margin reached -1580%. Total operating expenses were $17,540,000.
Profit Margin
| 2014 | 5.21M | -33.35M | -639.31% |
|---|---|---|---|
| 2015 | 19.26M | -24.39M | -126.66% |
| 2016 | 17.35M | -43.15M | -248.64% |
| 2017 | 7.99M | -51.50M | -644.25% |
| 2018 | 2.15M | -47.14M | -2191.96% |
| 2019 | 2.28M | -53.24M | -2325.91% |
| 2020 | 5.41M | -40.37M | -745.55% |
| 2021 | 2.81M | -35.09M | -1245.53% |
| 2022 | 1.77M | 47.75M | 2696.5% |
| 2023 | 651K | -10.28M | -1580.18% |
ACRX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 651K | 1.77M | 2.81M | 5.41M | 2.28M | 2.15M | 7.99M | 17.35M | 19.26M | 5.21M |
Cost of revenue | 0 | 2.59M | 3.75M | 6.03M | 6.80M | 3.97M | 10.65M | 12.31M | 1.77M | 0 |
Gross profit | 651K | -820K | -935K | -616K | -4.51M | -1.82M | -2.66M | 5.04M | 17.49M | 5.21M |
Operating exp. | ||||||||||
Research and development | 5.54M | 5.19M | 4.09M | 4.01M | 4.66M | 13.13M | 19.40M | 21.40M | 22.48M | 24.52M |
Selling and marketing | 0 | 0 | 0 | 0 | 1.1M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 17.54M | 30.86M | 35.03M | 40.34M | 49.68M | 33.90M | 36.01M | 36.99M | 36.69M | 42.86M |
Operating income | -16.88M | -36.63M | -35.96M | -40.96M | -54.20M | -35.72M | -38.68M | -31.95M | -19.95M | -37.64M |
Other income (expenses), net | 6.60M | 84.40M | 871K | 588K | 968K | -11.42M | -13.52M | -11.23M | -3.68M | 4.29M |
Income before tax | -10.28M | 47.76M | -35.09M | -40.37M | -53.23M | -47.14M | -52.20M | -43.19M | -23.63M | -33.35M |
Income tax expense | 0 | 13K | 5K | 4K | 3K | 2K | -701K | -34K | 760K | 6.93M |
Net income | -10.28M | 47.75M | -35.09M | -40.37M | -53.24M | -47.14M | -51.50M | -43.15M | -24.39M | -33.35M |
Earnings per share | ||||||||||
Basic EPS | -0.00 | 5.73 | -5.86 | -9.47 | -13.45 | -16.14 | -21.97 | -19.05 | -11.02 | -15.36 |
Diluted EPS | -0.00 | 5.72 | -5.86 | -9.47 | -13.45 | -16.14 | -21.97 | -19.05 | -10.97 | -15.05 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |